FDA Investigator Daniel J Min
Daniel J Min has conducted inspections on 14 sites in 1 countries as of 28 Jun 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
28 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Daniel J Min:
Adetutu M Gidado,
Alice S Tsao,
Alison N Correll,
Alison N Stieg,
Allison A Aldridge, PhD,
Amit Kokate,
Amy Chen,
Amy N Chen,
Anastasia I Offordile,
Anastasia M Shields,
Anita R Michael,
Ankur C Patel,
Audrey Thereset Uy,
Barbara Jwilimczyk Macri,
Brandy N Lepage,
Christina K Theodorou,
Craig D Zagata,
Cynthia A Palmer,
Daniel J Deciero,
David A Oluwo,
Deborah J Parris,
Douglas C Kovacs,
Elaine E Gilfillan,
Elaine Gilfillan,
Emmanuel Jramos Maldonado,
Erin D Mccaffery,
Fred Razzaghi,
Frederick F Razzaghi,
Gayle S Lawson,
Hala L Selby,
Helen Verdel,
James M Mason,
James R Birkenstamm,
Janet A Rajan,
Jogy George,
Jonathan G Matrisciano,
Joy Rkozlowski Klena,
Juanita P Versace,
Junho Pak,
Karen E D'orazio,
Kendra L Brooks,
Ko U Min,
Lata C Mathew, PhD,
LCDR Margaret Edi Gennaro,
Luis A Dasta,
Marcellinus D Dordunoo,
Margaret Faulkner,
Maria A Reed,
Matthew R Noonan,
Melissa T Roy,
Michael A Taylor,
Michael J Nerz,
Michael L Casner,
Michael R Klapal,
Nancy F Scheraga,
Nancy M Espinal,
Natasha Gupta,
Nicholas A Violand,
Niketa Patel,
Odera I Ekwunife,
Paul L Bellamy,
Puspa Suresh Jayasekara,
Qin Xu,
Rachael O Oyewole,
Raffi B Papazian,
Rose Ljean Mary,
Russell J Glapion,
Saleem A Akhtar,
Sam Pepe,
Sayyem H Akbar,
Stephanie Mangigian, MS/OSH, RN,
Tajah L Blackburn,
Tammy L Chavis,
Tanya R Syffrard,
Tekalign Wondimu,
Thomas E Friel,
Tiffani D Wilson,
Tonia F Bernard,
Tyanna N Hadley,
Vlada Matusovsky,
Youmin Wang
Daniel J Min's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2023 | FDA 483 | Medical Products Laboratories, Inc. - Form 483, 2023-07-13 |
December, 2021 | FDA 483 | Sigmapharm Laboratories, LLC - Form 483, 2021-12-07 |
May, 2022 | FDA 483 | Ferring Production Inc. - Form 483, 2022-05-12 |
June, 2022 | FDA 483 | Mandell's Clinical Pharmacy - Form 483, 2022-06-17 |
July, 2021 | FDA 483 | ACINO PRODUCTS LIMITED LIABILITY COMPANY - Form 483, 2021-07-01 |
August, 2022 | EIR | New Dawn Manufacturing - EIR, 2022-08-29 |
April, 2023 | FDA 483 | AustarPharma LLC - Form 483, 2023-04-05 |
December, 2022 | FDA 483 | Northern VA Compounders PLLC - Form 483, 2022-12-09 |
March, 2023 | FDA 483 | I 3 PHARMACEUTICALS, LLC - Form 483, 2023-03-03 |
May, 2021 | FDA 483 | Dercher Enterprises, Inc., DBA Gordon Laboratories - Form 483, 2021-05-04 |
February, 2022 | FDA 483 | I 3 PHARMACEUTICALS, LLC - Form 483, 2022-02-22 |
September, 2021 | FDA 483 | AZZUR LABS, LLC - Form 483, 2021-09-24 |
August, 2021 | FDA 483 | Coupler LLC - Form 483, 2021-08-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more